Nanomaterials have revolutionized the world of cancer
therapy, and plant-derived nanoparticles have the added advantage
of being cost-effective and easy to mass produce. Researchers from
Tokyo University of Science have recently developed novel
corn-derived bionanoparticles for targeting cancer cells directly,
via an immune mechanism. The results are encouraging, and the
technique has demonstrated efficacy in treating tumor-bearing
laboratory mice. Moreover, no serious adverse effects have been
reported in mice so far.
Researchers develop a nanoparticle-based drug delivery
system based on corn to target cancer cells
